CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...

This repository is the official implementation of our paper Any Target Can be Offense: Adversarial Example Generation via Generalized Latent Infection. Motivation: Traditional targeted attacks are ...

Treatment with cemdisiran was associated with a statistically significant improvement in MG-ADL total score compared with placebo. Topline results were announced from a phase 3 trial evaluating ...

Derivative-free method to find zeros of analytic (holomorphic) functions / solve nonlinear (polynomial / generalized) eigenvalue problems using contour integration. (Block SS-Hankel method, Block ...

Among various vertical coordinate systems, the sigma coordinate—a terrain-following approach fitted to seabed topography—has been most widely used in coastal and continental shelf seas. However, it ...

Myasthenia gravis is a lifelong (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--H2O.ai, the #1 Agentic AI company, announced its h2oGPTe Agent has once again achieved the top ranking on the prestigious General AI Assistant (GAIA) benchmark, ...

Imaavy is the first FcRn blocker approved for anti-AChR and anti-MuSK antibody positive patients with generalized myasthenia gravis. The Food and Drug Administration (FDA) has approved Imaavy ™ ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older with generalized myasthenia gravis based on data from the ongoing ...